Literature DB >> 30012583

The Conorfamide RPRFa Stabilizes the Open Conformation of Acid-Sensing Ion Channel 3 via the Nonproton Ligand-Sensing Domain.

Melissa Reiners1, Michael A Margreiter1, Adrienne Oslender-Bujotzek1, Giulia Rossetti1, Stefan Gründer2, Axel Schmidt2.   

Abstract

Acid-sensing ion channel 3 (ASIC3) is a proton-gated Na+ channel with important roles in pain. ASIC3 quickly desensitizes in less than a second, limiting its capacity to sense sustained acidosis during pain. RFamide neuropeptides are modulators of ASIC3 that slow its desensitization and induce a variable sustained current. The molecular mechanism of slowed desensitization and the RFamide binding site on ASIC3 are unknown. RPRFamide, a RFamide from the venom of a cone snail, has a comparatively high affinity for ASIC3 and strongly slows its desensitization. Here we show that covalent binding of a UV-sensitive RPRFamide variant to ASIC3 prevents desensitization, suggesting that RPRFamide has to unbind from ASIC3 before it can desensitize. Moreover, we show by in silico docking to a homology model of ASIC3 that a cavity in the lower palm domain, which is also known as the nonproton ligand-sensing domain, is a potential binding site of RPRFamide. Finally, using extensive mutagenesis of residues lining the nonproton ligand-sensing domain, we confirm that this domain is essential for RPRFamide modulation of ASIC3. As comparative analysis of ASIC crystal structures in the open and in the desensitized conformation suggests that the lower palm domain contracts during desensitization, our results collectively suggest that RPRFamide, and probably also other RFamide neuropeptides, bind to the nonproton ligand-sensing domain to stabilize the open conformation of ASIC3.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30012583     DOI: 10.1124/mol.118.112375

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Mechanism and site of action of big dynorphin on ASIC1a.

Authors:  Christian B Borg; Nina Braun; Stephanie A Heusser; Yasmin Bay; Daniel Weis; Iacopo Galleano; Camilla Lund; Weihua Tian; Linda M Haugaard-Kedström; Eric P Bennett; Timothy Lynagh; Kristian Strømgaard; Jacob Andersen; Stephan A Pless
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-12       Impact factor: 11.205

2.  Screening of 109 neuropeptides on ASICs reveals no direct agonists and dynorphin A, YFMRFamide and endomorphin-1 as modulators.

Authors:  Anna Vyvers; Axel Schmidt; Dominik Wiemuth; Stefan Gründer
Journal:  Sci Rep       Date:  2018-12-20       Impact factor: 4.379

3.  Mutations in the palm domain disrupt modulation of acid-sensing ion channel 1a currents by neuropeptides.

Authors:  Benoîte Bargeton; Justyna Iwaszkiewicz; Gaetano Bonifacio; Sophie Roy; Vincent Zoete; Stephan Kellenberger
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

4.  Acid-sensing ion channel 3: An analgesic target.

Authors:  Jasdip Singh Dulai; Ewan St John Smith; Taufiq Rahman
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

5.  The Neuropeptide Nocistatin Is Not a Direct Agonist of Acid-Sensing Ion Channel 1a (ASIC1a).

Authors:  Sven Kuspiel; Dominik Wiemuth; Stefan Gründer
Journal:  Biomolecules       Date:  2021-04-13

Review 6.  Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Authors:  Xin Yi Yeo; Grace Cunliffe; Roger C Ho; Su Seong Lee; Sangyong Jung
Journal:  Biomedicines       Date:  2022-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.